You might be surprised to learn that data storage currently requires huge amounts of land and energy, and we're running out of both. In this episode, we speak with a group of researchers who are revolutionizing the way we store massive amounts of data. Their solution: DNA.
Guests include: Emily Leproust, Twist Bioscience; Kyle Tomek, DNALi Data Technologies; Jeff Nivala, University of Washington
Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.
A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.
Speakers: Anna Hyde - Arthritis Foundation, Dan Durham - BIO, Dr. Vinay Rathi - Massachusetts Eye and Ear and Mass General Brigham
Alzheimer’s disease is a heartbreaking diagnosis and tragically there is no cure. But every day, researchers, scientists and the medical community are working to change that. In this episode, we speak with three guests who are fighting to bend the trajectory of Alzheimer’s disease and, in doing so, offering hope for the millions suffering from this devastating illness.
Last December, a United Airlines flight from Chicago to Washington DC was the first ever passenger flight powered with 100% sustainable aviation fuel. The achievement demonstrated the potential for the aviation sector to reduce its carbon footprint. Our guests in this episode each played a key role in helping the airline reach this exciting milestone.
Speakers: Laura Riley, Chief Sustainability Officer at United; Dave Kettner, President & CEO of Virent, Inc.
2021 was the unofficial year of mRNA—and deservedly so. But the science behind the technology is not always easy to understand. In this episode, we will dive into the miracle technology that saved countless lives and why the healthcare ecosystem will always need multiple options.
More than two-thirds of the Earth’s surface is water, and yet water that is safe enough for human consumption remains a finite resource. In this episode, we speak to experts about the biggest threats to water—contamination, overuse, and plastic. We also learn how innovative new tools can ensure there is enough water to hydrate us, our plants, and our animals.
Speakers: Ameen Razavi, Microvi Biotech; Dr. Joel Cuello, University of Arizona; Scott Tuten, Danimer Scientific